188 related articles for article (PubMed ID: 16422211)
1. [Importance of air-trapping in patients with COPD. Pathophysiological principle].
Voshaar TH
Med Klin (Munich); 2005 Oct; 100 Suppl 1():5-8. PubMed ID: 16422211
[TBL] [Abstract][Full Text] [Related]
2. The connection between chronic obstructive pulmonary disease symptoms and hyperinflation and its impact on exercise and function.
Cooper CB
Am J Med; 2006 Oct; 119(10 Suppl 1):21-31. PubMed ID: 16996896
[TBL] [Abstract][Full Text] [Related]
3. Diffusing capacity for carbon monoxide is linked to ventilatory demand in patients with chronic obstructive pulmonary disease.
Mahut B; Chevalier-Bidaud B; Plantier L; Essalhi M; Callens E; Graba S; Gillet-Juvin K; Valcke-Brossollet J; Delclaux C
COPD; 2012 Feb; 9(1):16-21. PubMed ID: 22292594
[TBL] [Abstract][Full Text] [Related]
4. [Bronchodilators reduce air-trapping in COPD patients].
Welte T
Med Klin (Munich); 2005 Oct; 100 Suppl 1():9-11. PubMed ID: 16422212
[TBL] [Abstract][Full Text] [Related]
5. [Effect of dynamic hyperinflation on exertional dyspnea, exercise performance and quality of life in COPD].
Ozgur ES; Atis S; Kanik A
Tuberk Toraks; 2008; 56(3):296-303. PubMed ID: 18932031
[TBL] [Abstract][Full Text] [Related]
6. Dyspnea and activity limitation in COPD: mechanical factors.
O'Donnell DE; Laveneziana P
COPD; 2007 Sep; 4(3):225-36. PubMed ID: 17729066
[TBL] [Abstract][Full Text] [Related]
7. Hyperinflation, dyspnea, and exercise intolerance in chronic obstructive pulmonary disease.
O'Donnell DE
Proc Am Thorac Soc; 2006 Apr; 3(2):180-4. PubMed ID: 16565429
[TBL] [Abstract][Full Text] [Related]
8. Exercise performance and dynamic hyperinflation in lymphangioleiomyomatosis.
Baldi BG; Albuquerque AL; Pimenta SP; Salge JM; Kairalla RA; Carvalho CR
Am J Respir Crit Care Med; 2012 Aug; 186(4):341-8. PubMed ID: 22700863
[TBL] [Abstract][Full Text] [Related]
9. Expiratory flow-limitation and heliox breathing in resting and exercising COPD patients.
D'Angelo E; Santus P; Civitillo MF; Centanni S; Pecchiari M
Respir Physiol Neurobiol; 2009 Dec; 169(3):291-6. PubMed ID: 19770071
[TBL] [Abstract][Full Text] [Related]
10. [Evaluation of dynamic hyperinflation parameters and exercise capacity at maximal exercise in patients with COPD].
Ulubay G; Görek A; Savaş S; Oner Eyüboğlu F
Tuberk Toraks; 2005; 53(4):340-6. PubMed ID: 16456732
[TBL] [Abstract][Full Text] [Related]
11. Longitudinal changes in hyperinflation parameters and exercise capacity after giant bullous emphysema surgery.
Neviere R; Catto M; Bautin N; Robin S; Porte H; Desbordes J; Matran R
J Thorac Cardiovasc Surg; 2006 Nov; 132(5):1203-7. PubMed ID: 17059944
[TBL] [Abstract][Full Text] [Related]
12. Similar dynamic hyperinflation during arm and leg exercise at similar ventilation in chronic obstructive pulmonary disease.
Hannink JD; Van Helvoort HA; Dekhuijzen PN; Heijdra YF
Med Sci Sports Exerc; 2011 Jun; 43(6):996-1001. PubMed ID: 21085035
[TBL] [Abstract][Full Text] [Related]
13. Respiratory muscle activity and dyspnea during exercise in chronic obstructive pulmonary disease.
Duiverman ML; de Boer EW; van Eykern LA; de Greef MH; Jansen DF; Wempe JB; Kerstjens HA; Wijkstra PJ
Respir Physiol Neurobiol; 2009 Jun; 167(2):195-200. PubMed ID: 19406254
[TBL] [Abstract][Full Text] [Related]
14. Effects of bronchodilators on dynamic hyperinflation following hyperventilation in patients with COPD.
Fujimoto K; Yoshiike F; Yasuo M; Kitaguchi Y; Urushihata K; Kubo K; Honda T
Respirology; 2007 Jan; 12(1):93-9. PubMed ID: 17207032
[TBL] [Abstract][Full Text] [Related]
15. Exercise capacity in chronic obstructive pulmonary disease: mechanisms of limitation.
Pepin V; Saey D; Laviolette L; Maltais F
COPD; 2007 Sep; 4(3):195-204. PubMed ID: 17729063
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of acute bronchodilator reversibility in patients with symptoms of GOLD stage I COPD.
O'Donnell DE; Laveneziana P; Ora J; Webb KA; Lam YM; Ofir D
Thorax; 2009 Mar; 64(3):216-23. PubMed ID: 19052054
[TBL] [Abstract][Full Text] [Related]
17. Does expiratory muscle activity influence dynamic hyperinflation and exertional dyspnea in COPD?
Laveneziana P; Webb KA; Wadell K; Neder JA; O'Donnell DE
Respir Physiol Neurobiol; 2014 Aug; 199():24-33. PubMed ID: 24793133
[TBL] [Abstract][Full Text] [Related]
18. Respiratory Sensations in Dynamic Hyperinflation: Physiological and Clinical Applications.
Soffler MI; Hayes MM; Schwartzstein RM
Respir Care; 2017 Sep; 62(9):1212-1223. PubMed ID: 28655742
[TBL] [Abstract][Full Text] [Related]
19. Mechanisms of dyspnoea relief and improved exercise endurance after furosemide inhalation in COPD.
Jensen D; Amjadi K; Harris-McAllister V; Webb KA; O'Donnell DE
Thorax; 2008 Jul; 63(7):606-13. PubMed ID: 18250181
[TBL] [Abstract][Full Text] [Related]
20. Pathophysiology of exercise dyspnea in healthy subjects and in patients with chronic obstructive pulmonary disease (COPD).
Grazzini M; Stendardi L; Gigliotti F; Scano G
Respir Med; 2005 Nov; 99(11):1403-12. PubMed ID: 16210095
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
